Abstract

Background: The urinary podocalyxin can served as a early detectible marker for nephropathy in patients with type 2 diabetes mellitus. Materials and Methods: This cross-sectional study included total ninety (90) subjects, whereas sixty were type 2 diabetes mellitus cases and remaining thirty were healthy controls. For all the subjects biochemical, clinical and experimental parameters are studied. Results: The type 2 diabetes mellitus patients showed a significant increased levels of urinary podocalyxin when compared to healthy controls. Among, the cases the type 2 diabetes mellitus patients with microalbuminuria showed a significantly higher levels of urinary podocalyxin than the type diabetes mellitus with normoalbuminuria. The urinary podocalyxin levels are significant positive correlation with microalbumin and negative correlation with eGFR. Conclusion: The urinary podocalyxin determination might be used as early predictable marker for type 2 diabetic nephropathy.

Description